Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Atrisorb FreeFlow
- Development stage
- Unknown
- Lead developer
- QLT
- Modality
- Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Topical
01
Overview
Atrisorb FreeFlow is a bioabsorbable guided tissue regeneration (GTR) barrier system used in periodontal surgery to treat periodontal defects and facilitate the regeneration of bone and tissue. Developed by Atrix Laboratories and later marketed by Block Drug Corporation and Tolmar, the product consists of a flowable polylactic acid (PLA) polymer gel. When applied to a surgical site, the material sets in the presence of water or oral fluids to form a semi-rigid, porous membrane. This membrane acts as a physical barrier that prevents epithelial downgrowth into the defect, thereby allowing for the selective repopulation of the root surface by periodontal ligament cells and bone-forming cells. Atrisorb FreeFlow is classified as a medical device and received FDA 510(k) clearance for the surgical treatment of periodontal disease.
- Brand names
- Atrisorb FreeFlow
- Other names
- Atrisorb
Beyond the preview
Go deeper on Atrisorb FreeFlow.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Atrisorb FreeFlow.